All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Poly[N‐(2‐hydroxypropyl)methacrylamide]‐modified magnetic .gamma.‐F2O3 nanoparticles conjugated with doxorubicin for glioblastoma treatment

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61389013%3A_____%2F20%3A00519564" target="_blank" >RIV/61389013:_____/20:00519564 - isvavai.cz</a>

  • Alternative codes found

    RIV/68378041:_____/20:00519564 RIV/61383082:_____/20:00000689 RIV/00216208:11110/20:10400428 RIV/00216208:11130/20:10400428

  • Result on the web

    <a href="https://chemistry-europe.onlinelibrary.wiley.com/doi/full/10.1002/cmdc.201900564" target="_blank" >https://chemistry-europe.onlinelibrary.wiley.com/doi/full/10.1002/cmdc.201900564</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1002/cmdc.201900564" target="_blank" >10.1002/cmdc.201900564</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Poly[N‐(2‐hydroxypropyl)methacrylamide]‐modified magnetic .gamma.‐F2O3 nanoparticles conjugated with doxorubicin for glioblastoma treatment

  • Original language description

    With the aim to develop a new anticancer agent, we prepared poly[N‐(2‐hydroxypropyl)methacrylamide‐co‐methyl 2‐methacrylamidoacetate] [P(HP‐MMAA)], which was reacted with hydrazine to poly[N‐(2‐hydroxypropyl)methacrylamide‐co‐N‐(2‐hydrazinyl‐2‐oxoethyl)methacrylamide] [P(HP‐MAH)] to conjugate doxorubicin (Dox) via hydrazone bond. The resulting P(HP‐MAH)‐Dox conjugate was used as a coating of magnetic γ‐Fe2O3 nanoparticles obtained by the coprecipitation method. In vitro toxicity of various concentrations of Dox, P(HP‐MAH)‐Dox, and γ‐Fe2O3@P(HP‐MAH)‐Dox nanoparticles was determined on somatic healthy cells (human bone marrow stromal cells hMSC), human glioblastoma line (GaMG), and primary human glioblastoma (GBM) cells isolated from GBM patients both at a short and prolonged exposition time (up to 7 days). Due to hydrolysis of the hydrazone bond in acid milieu of tumor cells and Dox release, the γ‐Fe2O3@P(HP‐MAH)‐Dox nanoparticles significantly decreased the GaMG and GBM cell growth compared to free Dox and P(HP‐MAH)‐Dox in low concentration (10 nM), whereas in hMSCs it remained without effect. γ‐F2O3@PHP nanoparticles alone did not affect the viability of any of the tested cells.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    10404 - Polymer science

Result continuities

  • Project

    <a href="/en/project/GA17-04918S" target="_blank" >GA17-04918S: Treating Glioblastoma with surface engineered superparamagnetic iron oxide nanoparticles for efficient conjugation with anticancer drugs</a><br>

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2020

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    ChemMedChem

  • ISSN

    1860-7179

  • e-ISSN

  • Volume of the periodical

    15

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    DE - GERMANY

  • Number of pages

    9

  • Pages from-to

    96-104

  • UT code for WoS article

    000495798800001

  • EID of the result in the Scopus database

    2-s2.0-85075201973